ID UD2B1_RAT Reviewed; 529 AA. AC P09875; DT 01-JUL-1989, integrated into UniProtKB/Swiss-Prot. DT 01-JUL-1989, sequence version 1. DT 02-SEP-2026, entry version 175. DE RecName: Full=UDP-glucuronosyltransferase 2B1 {ECO:0000303|PubMed:18719240}; DE Short=UDPGT 2B1; DE Short=UGT2B1; DE EC=2.4.1.17 {ECO:0000269|PubMed:18719240}; DE AltName: Full=UDPGTr-2; DE Flags: Precursor; GN Name=Ugt2b1 {ECO:0000312|RGD:708541}; Synonyms=Udpgtr2; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION. RC TISSUE=Liver; RX PubMed=3084479; DOI=10.1016/s0021-9258(17)38500-9; RA McKenzie P.I.; RT "Rat liver UDP-glucuronosyltransferase. Sequence and expression of a cDNA RT encoding a phenobarbital-inducible form."; RL J. Biol. Chem. 261:6119-6125(1986). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=2113533; DOI=10.1016/s0021-9258(19)38595-3; RA McKenzie P.I., Rodbourn L.; RT "Organization of the rat UDP-glucuronosyltransferase, UDPGTr-2, gene and RT characterization of its promoter."; RL J. Biol. Chem. 265:11328-11332(1990). RN [3] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=18719240; DOI=10.1124/dmd.108.022731; RA Itaeaho K., Mackenzie P.I., Ikushiro S., Miners J.O., Finel M.; RT "The configuration of the 17-hydroxy group variably influences the RT glucuronidation of beta-estradiol and epiestradiol by human UDP- RT glucuronosyltransferases."; RL Drug Metab. Dispos. 36:2307-2315(2008). CC -!- FUNCTION: UDP-glucuronosyltransferase (UGT) that catalyzes phase II CC biotransformation reactions in which lipophilic substrates are CC conjugated with glucuronic acid to increase the metabolite's water CC solubility, thereby facilitating excretion into either the urine or CC bile (PubMed:18719240). Essential for the elimination and CC detoxification of drugs, xenobiotics and endogenous compounds CC (PubMed:18719240). Catalyzes the glucuronidation of the endogenous CC estrogen hormone estradiol (PubMed:18719240). CC {ECO:0000269|PubMed:18719240}. CC -!- CATALYTIC ACTIVITY: CC Reaction=glucuronate acceptor + UDP-alpha-D-glucuronate = acceptor CC beta-D-glucuronoside + UDP + H(+); Xref=Rhea:RHEA:21032, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, CC ChEBI:CHEBI:132367, ChEBI:CHEBI:132368; EC=2.4.1.17; CC Evidence={ECO:0000269|PubMed:18719240}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21033; CC Evidence={ECO:0000305|PubMed:18719240}; CC -!- CATALYTIC ACTIVITY: CC Reaction=17beta-estradiol + UDP-alpha-D-glucuronate = 17beta-estradiol CC 17-O-(beta-D-glucuronate) + UDP + H(+); Xref=Rhea:RHEA:52464, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:16469, ChEBI:CHEBI:58052, CC ChEBI:CHEBI:58223, ChEBI:CHEBI:82961; CC Evidence={ECO:0000269|PubMed:18719240}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52465; CC Evidence={ECO:0000305|PubMed:18719240}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=13.4 uM for 17beta-estradiol/estradiol (when assaying CC glucuronidation at position 17) {ECO:0000269|PubMed:18719240}; CC Vmax=1630 pmol/min/mg enzyme for the formation of 17beta-estradiol CC 17-O-(beta-D-glucuronate) {ECO:0000269|PubMed:18719240}; CC Vmax=55 pmol/min/mg enzyme for the formation of 17beta-estradiol CC 3-O-(beta-D-glucuronate) {ECO:0000269|PubMed:18719240}; CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000305|PubMed:3084479}; Single-pass membrane protein CC {ECO:0000255}. CC -!- INDUCTION: By phenobarbital. {ECO:0000305}. CC -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M13506; AAA42313.1; -; mRNA. DR EMBL; M35086; AAA42310.1; -; Genomic_DNA. DR EMBL; M35202; AAA42310.1; JOINED; Genomic_DNA. DR EMBL; M35080; AAA42310.1; JOINED; Genomic_DNA. DR EMBL; M35082; AAA42310.1; JOINED; Genomic_DNA. DR EMBL; M35083; AAA42310.1; JOINED; Genomic_DNA. DR PIR; A42233; A42233. DR RefSeq; NP_775417.1; NM_173295.2. DR AlphaFoldDB; P09875; -. DR SMR; P09875; -. DR FunCoup; P09875; 346. DR IntAct; P09875; 5. DR STRING; 10116.ENSRNOP00000002724; -. DR SwissLipids; SLP:000001699; -. DR CAZy; GT1; Glycosyltransferase Family 1. DR GlyCosmos; P09875; 2 sites, No reported glycans. DR GlyGen; P09875; 2 sites. DR iPTMnet; P09875; -. DR PhosphoSitePlus; P09875; -. DR PaxDb; 10116-ENSRNOP00000002724; -. DR Ensembl; ENSRNOT00000139046.1; ENSRNOP00000104488.1; ENSRNOG00000001990.6. DR GeneID; 286954; -. DR KEGG; rno:286954; -. DR UCSC; RGD:708541; rat. DR AGR; RGD:708541; -. DR CTD; 71773; -. DR RGD; 708541; Ugt2b1. DR eggNOG; KOG1192; Eukaryota. DR GeneTree; ENSGT00940000153212; -. DR InParanoid; P09875; -. DR OMA; EFSDQMT; -. DR OrthoDB; 5835829at2759; -. DR PhylomeDB; P09875; -. DR BRENDA; 2.4.1.17; 5301. DR Reactome; R-RNO-156588; Glucuronidation. DR Reactome; R-RNO-9749641; Aspirin ADME. DR Reactome; R-RNO-9757110; Prednisone ADME. DR SABIO-RK; P09875; -. DR PRO; PR:P09875; -. DR Proteomes; UP000002494; Chromosome 14. DR Bgee; ENSRNOG00000001990; Expressed in duodenum and 11 other cell types or tissues. DR ExpressionAtlas; P09875; baseline and differential. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell. DR GO; GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB. DR GO; GO:0070980; P:biphenyl catabolic process; IDA:RGD. DR GO; GO:0071361; P:cellular response to ethanol; IEP:RGD. DR GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IEP:RGD. DR GO; GO:0071378; P:cellular response to growth hormone stimulus; IEP:RGD. DR GO; GO:0071394; P:cellular response to testosterone stimulus; IEP:RGD. DR GO; GO:0008210; P:estrogen metabolic process; IDA:UniProtKB. DR GO; GO:0051291; P:protein heterooligomerization; ISO:RGD. DR GO; GO:0051260; P:protein homooligomerization; ISO:RGD. DR GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD. DR GO; GO:0006805; P:xenobiotic metabolic process; TAS:RGD. DR CDD; cd03784; GT1_Gtf-like; 1. DR FunFam; 3.40.50.2000:FF:000001; UDP-glucuronosyltransferase; 1. DR FunFam; 3.40.50.2000:FF:000081; UDP-glucuronosyltransferase 2A2; 1. DR Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 2. DR InterPro; IPR050271; UDP-glycosyltransferase. DR InterPro; IPR002213; UDP_glucos_trans. DR InterPro; IPR035595; UDP_glycos_trans_CS. DR PANTHER; PTHR48043; EG:EG0003.4 PROTEIN-RELATED; 1. DR PANTHER; PTHR48043:SF12; UDP-GLUCURONOSYLTRANSFERASE 2B4; 1. DR Pfam; PF00201; UDPGT; 1. DR SUPFAM; SSF53756; UDP-Glycosyltransferase/glycogen phosphorylase; 1. DR PROSITE; PS00375; UDPGT; 1. PE 1: Evidence at protein level; KW Endoplasmic reticulum; Glycoprotein; Glycosyltransferase; Membrane; KW Reference proteome; Signal; Transferase; Transmembrane; KW Transmembrane helix. FT SIGNAL 1..23 FT /evidence="ECO:0000250" FT CHAIN 24..529 FT /note="UDP-glucuronosyltransferase 2B1" FT /id="PRO_0000036025" FT TRANSMEM 494..510 FT /note="Helical" FT /evidence="ECO:0000255" FT CARBOHYD 134 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 316 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" SQ SEQUENCE 529 AA; 60485 MW; 14DF0224BF1C3044 CRC64; MSMKQTSVFL LIQLICYFRP GACGKVLVWP TEYSHWINIK IILNELAQRG HEVTVLVSSA SILIEPTKES SINFEIYSVP LSKSDLEYSF AKWIDEWTRD FETLSIWTYY SKMQKVFNEY SDVVENLCKA LIWNKSLMKK LQGSQFDVIL ADAVGPCGEL LAELLKTPLV YSLRFCPGYR CEKFSGGLPL PPSYVPVVLS ELSDRMTFVE RVKNMLQMLY FDFWFQPFKE KSWSQFYSDV LGRPTTLTEM MGKADIWLIR TFWDLEFPHP FLPNFDFVGG LHCKPAKPLP REMEEFVQSS GEHGVVVFSL GSMVKNLTEE KANVVASALA QIPQKVVWRF DGKKPDTLGS NTRLYKWIPQ NDLLGHPKTK AFVAHGGTNG IYEAIYHGIP IVGIPLFADQ PDNINHMVAK GAAVRVDFSI LSTTGLLTAL KIVMNDPSYK ENAMRLSRIH HDQPVKPLDR AVFWIEYVMR HKGAKHLRST LHDLSWFQYH SLDVIGFLLL CVVGVVFIIT KFCLFCCRKT ANMGKKKKE //